blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1013760

EP1013760 - Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.11.2003
Database last updated on 20.09.2024
Most recent event   Tooltip19.01.2004Lapse of the patent in a contracting state
New state(s): BE		published on 03.03.2004  [2004/10]
Applicant(s)For all designated states
XOMA Technology Ltd.
c/o XOMA (US) LLC, 2910 Seventh Street
Berkeley, CA 94710 / US
[2000/36]
Former [2000/26]For all designated states
Xoma Technology Lt.
Clarendon House, 2 Church Street
Hamilton HM11 / BM
Inventor(s)01 / Theofan, Georgia
2817 Jacaranda Avenue
Carlsbad, California 92009 / US
02 / Baltaian, Manik
461 Myrtle
Glendale, California 91203 / US
03 / Horwitz, Arnold
7529 Midfield
Los Angeles, California 90045 / US
04 / Grinna, Lynn
P.O. Box 2260
Middleburg, VA 22117 / US
05 / Burke, David
5957 Chabolyn Terrace
Oakland, California 94618 / US
[2000/41]
Former [2000/26]01 / Theofan, georgia
3014 Sonoma Street
Torrence, California 90503 / US
02 / Baltaian, Manik
461 Myrtle
Glendale, California 91203 / US
03 / Horwitz, Arnold
7529 Midfield
Los Angeles, California 90045 / US
04 / Grinna, Lynn
P.O. Box 2260
Middleburg, VA 22117 / US
05 / Burke, David
5957 Chabolyn Terrace
Oakland, California 94618 / US
Representative(s)Richardson, Kate
Forrester & Boehmert, Pettenkoferstrasse 20-22
80336 München / DE
[N/P]
Former [2000/26]Richardson, Kate
Forrester & Boehmert, Franz-Joseph Strasse 38
80801 München / DE
Application number, filing date00103901.502.02.1994
[2000/26]
Priority number, dateUS1993001380102.02.1993         Original published format: US 13801
[2000/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1013760
Date:28.06.2000
Language:EN
[2000/26]
Type: A3 Search report 
No.:EP1013760
Date:09.08.2000
[2000/32]
Type: B1 Patent specification 
No.:EP1013760
Date:08.01.2003
Language:EN
[2003/02]
Search report(s)(Supplementary) European search report - dispatched on:EP26.06.2000
ClassificationIPC:C12N15/12, C07K14/47, A61K38/17
[2000/26]
CPC:
C07K19/00 (EP,US); C12N15/11 (KR); A61K38/16 (KR);
A61P11/00 (EP); A61P13/12 (EP); A61P29/00 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P39/00 (EP);
A61P39/02 (EP); A61P7/00 (EP); A61P7/02 (EP);
A61P7/06 (EP); A61P9/02 (EP); C07K14/47 (KR);
C07K14/4742 (EP,US); C12N15/85 (EP,US); C12P21/02 (KR);
A61K38/00 (EP,US); C07K2319/00 (EP,US); C12N2830/00 (EP,US);
C12N2830/15 (EP,US); C12N2830/30 (EP,US); C12N2830/60 (EP,US);
C12N2830/85 (EP,US); C12N2840/44 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/26]
TitleGerman:Stabile Produkte des bakterientötenden/durchlässigkeiterhöhenden Proteins (PBI) und diese enthaltende Arzneimittelzusammensetzungen[2000/26]
English:Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same[2000/26]
French:Produits stables de la protéine bactéricide augmentant la perméabilité et compositions thérapeutiques les contenant[2000/26]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure24.02.2000Examination requested  [2000/26]
13.11.2000Request for accelerated examination filed
18.05.2001Despatch of a communication from the examining division (Time limit: M04)
18.05.2001Decision about request for accelerated examination - accepted: Yes
28.09.2001Reply to a communication from the examining division
18.02.2002Despatch of communication of intention to grant (Approval: No)
28.06.2002Despatch of communication of intention to grant (Approval: later approval)
24.07.2002Communication of intention to grant the patent
30.10.2002Fee for grant paid
30.10.2002Fee for publishing/printing paid
Parent application(s)   TooltipEP94908704.3  / EP0689592
Divisional application(s)EP03000252.1  / EP1310558
Opposition(s)09.10.2003No opposition filed within time limit [2004/01]
Fees paidRenewal fee
24.02.2000Renewal fee patent year 03
24.02.2000Renewal fee patent year 04
24.02.2000Renewal fee patent year 05
24.02.2000Renewal fee patent year 06
24.02.2000Renewal fee patent year 07
15.02.2001Renewal fee patent year 08
13.02.2002Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT08.01.2003
BE08.01.2003
CH08.01.2003
GR08.01.2003
LI08.01.2003
NL08.01.2003
DK08.04.2003
PT08.04.2003
SE08.04.2003
ES30.07.2003
[2004/10]
Former [2004/04]AT08.01.2003
CH08.01.2003
GR08.01.2003
LI08.01.2003
NL08.01.2003
DK08.04.2003
PT08.04.2003
SE08.04.2003
ES30.07.2003
Former [2004/02]AT08.01.2003
CH08.01.2003
GR08.01.2003
LI08.01.2003
NL08.01.2003
DK08.04.2003
PT08.04.2003
SE08.04.2003
Former [2003/47]AT08.01.2003
CH08.01.2003
GR08.01.2003
LI08.01.2003
NL08.01.2003
PT08.04.2003
SE08.04.2003
Former [2003/43]CH08.01.2003
GR08.01.2003
LI08.01.2003
NL08.01.2003
PT08.04.2003
SE08.04.2003
Former [2003/41]CH08.01.2003
GR08.01.2003
LI08.01.2003
NL08.01.2003
SE08.04.2003
Former [2003/40]CH08.01.2003
GR08.01.2003
LI08.01.2003
SE08.04.2003
Former [2003/31]GR08.01.2003
SE08.04.2003
Former [2003/30]SE08.04.2003
Documents cited:Search[A]  - WEISS, J. ET AL., "Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant Gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.", JOURNAL OF CLINICAL INVESTIGATIONS, (199209), vol. 90, pages 1122 - 30, XP000914563 [A] * the whole document *

DOI:   http://dx.doi.org/10.1172/JCI115930
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.